Skip to content

TMS

When Does TMS Start Working? What to Expect Week by Week

Many patients who benefit from TMS notice changes around weeks 2–3, but improvement can build throughout a 4–6 week course. Little early change does not prove that treatment will be ineffective.

Written by Dr. Chi Hung Au, Psychiatrist

3 min read

How long does TMS take to work for depression?

Many patients who benefit from transcranial magnetic stimulation (TMS) begin to notice changes around two to three weeks into a standard course of weekday treatment. However, this is not a deadline. Meaningful improvement may continue to develop throughout a four-to-six-week acute course, and some patients respond later.

The timeline depends partly on the TMS protocol, number and frequency of sessions, individual clinical factors and how improvement is measured. Not all protocols have identical evidence or schedules, so the treating clinician should explain what applies to a particular treatment plan.

What do response and remission mean?

A first noticeable improvement may be a small change in symptoms or day-to-day functioning. A clinically meaningful response is a larger overall reduction in depression severity; in research, it is often defined as at least a 50% reduction on a symptom scale. Remission means symptoms have fallen below a defined low threshold—it does not mean that future care or monitoring is unnecessary.

These are different milestones. Someone may notice early improvement without yet meeting response criteria, or may have a meaningful response without reaching remission.

A typical week-by-week TMS trajectory

  • Week 1: Some people notice change, while many do not. An individual session is not expected to produce a dramatic or lasting shift.
  • Weeks 2–3: Improvement often becomes more perceptible among patients who respond. Symptom-rating scales may identify gradual change that is difficult to recognize day to day.
  • Weeks 4–6: Benefits may continue accumulating. Improvement is not necessarily linear; some people improve quickly, while others follow a slower, steadier course.
  • Beyond the standard course: For selected patients showing delayed or continuing improvement, a clinician may consider whether further sessions are appropriate. This requires individualized assessment.

What might TMS improvement feel like at first?

TMS improvement does not always feel like depression suddenly lifting. Early progress may appear as a modest change in overall symptom scores or an increased ability to manage ordinary activities. Research supports evaluating the trajectory across repeated measurements rather than expecting a clear effect after each session.

Changes can also fluctuate. A difficult day does not necessarily erase progress, just as one better day does not establish a sustained response.

What if TMS is not working after two or three weeks?

Do not conclude from early non-response alone that TMS has failed. In a large real-world registry, patients who ultimately received extended courses showed less improvement early on but continued to make steady gains; additional sessions beyond 36 were associated with further improvement. Because this was observational research, it cannot prove that more sessions caused the better outcomes.

The same registry found that shorter courses were associated with less benefit overall. Treatment duration may be influenced by many factors, so session number should not be interpreted as a guarantee. Instead, the clinician may review symptom scores, functioning, tolerability, attendance and the broader clinical picture before recommending whether to continue or adjust the plan.

NeuroLinks provides psychiatrist-led TMS assessment and treatment in Nanaimo for appropriately selected patients from Vancouver Island and elsewhere in British Columbia. Contact NeuroLinks to discuss whether an assessment or referral may be appropriate.

References

  1. Yosef A. Berlow, Amin Zandvakili, McKenna C. Brennan, Leanne M. Williams, Lawrence H. Price, Noah S. Philip. Modeling the antidepressant treatment response to transcranial magnetic stimulation using an exponential decay function. Scientific Reports 13(1) (2023)
  2. Todd M. Hutton, Scott T. Aaronson, Linda L. Carpenter, Kenneth Pages, David Krantz, Lindsay Lucas, et al.. Dosing transcranial magnetic stimulation in major depressive disorder: Relations between number of treatment sessions and effectiveness in a large patient registry. Brain Stimulation 16(5):1510-1521 (2023)

This article is educational and does not replace an individual psychiatric assessment. Medical review is recorded in the article details when completed.